Most eukaryotic genes contain intervening sequences, or introns, that are removed from mRNA precursor transcripts (pre-mRNAs) by the splicing machinery prior to export of mature mRNA from nucleus to cytoplasm. This nuclear splicing reaction is dependent on ATP hydrolysis and is catalysed by a large ribonucleoprotein complex called the spliceosome. The spliceosome consists of three major subunits -the U1, U2 and U4/5/6 small nuclear ribonucleoprotein particles (snRNPs) -together with an additional group of non-snRNP protein splicing factors. Splicing snRNPs are assembled from the respective U snRNAs -U1, U2 and U4/5/6 -and snRNP proteins. Some of these proteins are common to each snRNP, whereas others bind specifically to individual U snRNAs.
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Spliceosomes assemble on pre-mRNA in a stepwise reaction that is characterised by a dynamic sequence of changes in both snRNA-snRNA and snRNA-pre-mRNA base-pairing interactions. Thus, base-paired regions formed during early stages of assembly are later displaced and new base-pairing interactions formed, involving alterations of the secondary and tertiary structures of individual snRNA molecules (Figure 1 ). These alterations include the destabilisation and release of U4 snRNA from the complex as assembly proceeds. The splicing reaction presents the complex folding problem of aligning the conserved splice sites that flank introns, and RNA basepairing interactions play a major role in solving this problem. A key step towards understanding the splicing mechanism therefore involves understanding how RNA base-pairing interactions are formed and regulated within the spliceosome.
Genetic experiments in the budding yeast Saccharomyces cerevisiae have identified a group of seven genes -BRR2, PRP2, PRP5, PRP16, PRP22, PRP28 and PRP43 -which all encode members of the so called DEAD-box superfamily of proteins [1] . Mutation of each of these genes inhibits a different step in the splicing pathway, suggesting that they play distinct roles. The recent discovery of several human homologues of yeast DEAD-box protein splicing factors is consistent with their having important functions in the splicing mechanism.
Proteins in the DEAD-box superfamily are characterised by seven conserved domains, including the eponymous tetrapeptide DEAD -consensus sequence D-E-A/C/I-D/H -which inspired their name [2] (Figure 2 ). They can be classified further into subfamilies which have either the DEAD motif itself or else the variant motifs DExH or DEAH. Roles can be assigned to some of the conserved domains on the basis of a vast amount of structure-function data and insights gained from the recently solved crystal structures of three family members. Domain I is implicated in binding the triphosphate moiety of ATP, and the DE residues of the DEAD-box complex the Mg 2+ ions required to bind ATP. The last residue of the DEAD-box is likely to contact domain III, and this interaction is proposed to be crucial for transmission of a conformational change upon ATP hydrolysis. Non-specific RNA-binding activity has been attributed to domain VI, but it is still unclear whether DEAD-box proteins recognise specific RNA sequences, or how many RNA-binding domains they contain.
Proteins in the DEAD-box superfamily are involved in many biological processes. For example, the budding yeast genome encodes about 40 members of the DEADbox superfamily, including proteins which have been implicated in mRNA processing, ribosomal RNA maturation and translation. DEAD-box proteins are often described as 'helicases', as two of the first members of the family to be analysed, eIF4A and p68, were both shown to have helicase activity in vitro. It has proved difficult, however, to demonstrate helicase activity for most of the subsequently identified DEAD-box proteins, and so far in vitro helicase activity has been described for only a few DEAD-box proteins on artificial substrates [3] . Many DEAD-box proteins have been shown to bind both RNA and ATP, and can hydrolyse ATP in an RNA-dependent reaction that can trigger a conformational change in the protein. It may therefore be more accurate to describe DEAD-box proteins collectively as RNA-dependent ATPases rather than helicases.
The notion that DEAD-box protein splicing factors control the complex RNA base-pairing interactions in the spliceosome is attractive, but direct biochemical evidence in favour of this model has been conspicuously absent. Now several groups have reported that specific DEADbox protein splicing factors can disrupt RNA-RNA base pairing in vitro, which supports the view that they play an important role in modulating RNA-RNA interactions involved in splicing.
The most detailed evidence has been obtained for a DExH-box protein that associates stably with human U5 snRNA, called hU5-200k [4] . In a systematic search for RNA-dependent ATPases, Lührmann and coworkers used ultraviolet-crosslinking to identify ATP-binding proteins that interact with human U5 snRNA. Purification and sequencing of these ATP-binding proteins identified hU5-100k (yeast homologue Prp28) and hU5-200k (yeast homologue Brr2/SNU246/Slt22/Rss1), both members of the DEAD-box superfamily. hU5-200k is unique in having two copies of all seven conserved helicase domains, the first including the DEIH motif variant.
Lührmann and coworkers [4] went on to demonstrate that purified 20S U5 snRNPs can induce the ATPdependent dissociation of either deproteinized yeast U4-U6 snRNA hybrids or artificial RNA hybrids formed in vitro. U5 snRNPs lacking either hU5-100k or hU5-200k were generated by purifying U5 snRNPs that were partially dissociated by salt treatment, and they were used to show that the hU5-100k protein is not required for in vitro dissociation of U4-U6 snRNA hybrids. Instead, the RNA-dissociation activity could be attributed clearly to hU5-200k, confirmed by purifying the protein to near homogeneity.
These conclusions are complemented nicely by work of Guthrie and coworkers on yeast DEAD-box splicing factors [5, 6] . Brr2, the yeast homologue of hU5-200k, was identified by the cold-sensitive mutant brr2-1, which is defective for pre-mRNA splicing. As reported elsewhere in this issue, Raghunathan and Guthrie [5] have shown that Brr2 can dissociate U4 and U6 snRNPs from an RNP-complex containing U1, U2, U5 and U4/U6 snRNPs that was immunopurified with anti-Brr2 antibodies. The Brr2-mediated dissociation of U4 and U6 snRNAs is ATP-dependent, and is blocked by the brr2-1 mutation, which is a single glutamate for glycine substitution at residue 610 in the conserved, helicase-type motif adjacent to the DEIH tetrapeptide. Taken together, the results of these experiments identify hU5-200k/Brr2 as a strong candidate for being the factor that dissociates U4 and U6 snRNAs in the spliceosome.
Models derived from simplified in vitro reactions should be considered with caution, however, for these reactions might not mirror accurately the complex environment of the spliceosome. For example, some brr2 mutant alleles, such as SLT22-1, affect splicing at a stage after U4 snRNP dissociates from the spliceosome, suggesting that the in vivo role of hU5-200k/Brr2 might be more complicated. Furthermore, Raghunathan and Guthrie [5] found that Brr2 dissociated U4 and U6 from a multi-snRNP complex Dispatch R533
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Conserved domains of the DEAD-box protein superfamily and their possible functions. in the absence of pre-mRNA substrate. It thus remains to be shown whether hU5-200k/Brr2 performs a similar role within the spliceosome during the splicing reaction.
The yeast protein splicing factors Prp16 and Prp22 have also been shown to be capable of disrupting the RNA base pairing in vitro [6] [7] [8] . Prp16 is required before the second cleavage step of the splicing reaction, but after the release of U4 snRNP from the spliceosome (Figure 1) . It was suspected that Prp16 may be able to alter RNA-RNA interactions, as it has an NTPase activity stimulated by RNA, and a conformational change was known to occur in the spliceosome at or around the Prp16-dependent step. Recent work by Guthrie and coworkers [6] , and by Schwer and Gross [7] , has provided biochemical evidence to back up these suspicions. Recombinant Prp16 can dissociate both U4-U6 snRNA hybrids and artificial RNA hybrids, and this activity is blocked by non-hydrolysable ATP analogues. The reaction is not strictly ATP-dependent, however, because any rNTP or dNTP can substitute for ATP in the in vitro assay. Furthermore, dissociation of U4 and U6 snRNPs, as the authors themselves point out, is unlikely to be the major function of Prp16 in the spliceosome, because Prp16 activity is required only after U4 snRNP has left the spliceosome.
Inactivation of Prp22, the mammalian homologue of which is known as HRH1, results in accumulation of spliceosomes containing the splicing products -mRNA and the excised intron lariat. Prp22 has thus been described as a release or recycling factor required to dissociate splicing factors from the substrate RNA after completion of the splicing reaction. Recombinant Prp22 expressed in Escherichia coli is functional and can dissociate both U4-U6 snRNA hybrids and artificial RNA hybrids in an ATP-dependent reaction. Furthermore, a Prp22 variant carrying a mutation in domain I, the likely ATP-binding domain of DEAD-box proteins, does not promote the RNA dissociation reaction [8] . As for Prp16, however, the in vivo substrate of Prp22 is unlikely to be the U4-U6 snRNP, and further experiments are required to identify the true spliceosomal target of Prp22.
We have not described spliceosome-associated DEAD/DExH-box proteins as helicases or unwindases deliberately to avoid evoking images of processive enzymes travelling at high speed through long, double-helical regions of RNA. Neither processivity nor multiple turnover have been observed with DEAD-box proteins in the in vitro RNA dissociation reactions, and true 'helicase' activity is probably not required -and may even not be possiblein the context of the spliceosome. The RNA-RNA interactions that have to be altered during the splicing reaction are very short, usually 5-7 base pairs, corresponding approximately to the region covered by a single, static DEAD-box protein. Note also that the movement of many protein splicing factors, and particularly integral U snRNP proteins such as hU5-200k/Brr2, are probably constrained within the spliceosome. The function of DEAD-box splicing factors may thus be selectively to stabilise particular isomeric RNA structures in the spliceosome. In this view, ATP hydrolysis would induce a conformational change that results in the stabilisation of an alternative RNA structure [9] .
The recent demonstration that spliceosome-associated DEAD/DExH-box proteins can affect RNA-RNA interactions in an ATP-hydrolysis-dependent fashion is clearly an important development, and supports the view that they control RNA structure in the spliceosome. The important next step will be to identify the genuine in vivo substrates for these factors. Because the conserved domain of a DEAD-box protein is probably a module that couples structural changes to ATP hydrolysis, the protein's interactions with specific spliceosomal components are likely to be mediated by separate motifs in the amino-terminal and carboxy-terminal regions which are unique for individual DEAD-box proteins. Unwinding this spliceosomal network of protein-protein, RNA-protein and RNA-RNA interactions should advance our understanding of how conformational changes are regulated, and how they are timed to occur at the correct moment and in the correct place.
